171 related articles for article (PubMed ID: 10550566)
21. Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.
Kelly K; Lovato L; Bunn PA; Livingston RB; Zangmeister J; Taylor SA; Roychowdhury D; Crowley JJ; Gandara DR;
Clin Cancer Res; 2001 Aug; 7(8):2325-9. PubMed ID: 11489808
[TBL] [Abstract][Full Text] [Related]
22. Oral chemotherapy for poor risk small-cell lung cancer patients with combined idarubicin and etoposide.
Ardizzoni A; Pennucci C; Fusco V; Gulisano M; Bonavia M; Pronzato P; De Palma M; Serrano J; Rosso R
Anticancer Res; 1989; 9(4):937-9. PubMed ID: 2554789
[TBL] [Abstract][Full Text] [Related]
23. Achieving full-dose, on-schedule administration of ACE chemotherapy every 14 days for the treatment of patients with extensive small-cell lung cancer.
Pirker R; Ulsperger E; Messner J; Aigner K; Forstner B; Bacon P; Easton V; Skacel T
Lung; 2006; 184(5):279-85. PubMed ID: 17235728
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
Slevin ML; Clark PI; Joel SP; Malik S; Osborne RJ; Gregory WM; Lowe DG; Reznek RH; Wrigley PF
J Clin Oncol; 1989 Sep; 7(9):1333-40. PubMed ID: 2549204
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer.
Miller AA; Tolley EA; Niell HB; Stewart CF; Griffin JP
Cancer Chemother Pharmacol; 1992; 31(2):161-6. PubMed ID: 1333371
[TBL] [Abstract][Full Text] [Related]
26. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.
Samantas E; Skarlos DV; Pectasides D; Nicolaides P; Kalofonos H; Mylonakis N; Vardoulakis Th; Kosmidis P; Pavlidis N; Fountzilas G
Lung Cancer; 1999 Feb; 23(2):159-68. PubMed ID: 10217620
[TBL] [Abstract][Full Text] [Related]
28. A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.
James LE; Gower NH; Rudd RM; Spiro SG; Harper PG; Trask CW; Partridge M; Ruiz de Elvira MC; Souhami RL
Br J Cancer; 1996 Jun; 73(12):1563-8. PubMed ID: 8664131
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.
Clark PI; Slevin ML; Joel SP; Osborne RJ; Talbot DI; Johnson PW; Reznek R; Masud T; Gregory W; Wrigley PF
J Clin Oncol; 1994 Jul; 12(7):1427-35. PubMed ID: 8021734
[TBL] [Abstract][Full Text] [Related]
30. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.
Girling DJ
Lancet; 1996 Aug; 348(9027):563-6. PubMed ID: 8774567
[TBL] [Abstract][Full Text] [Related]
31. Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group study.
Goodman GE; Crowley J; Livingston RB; Rivkin SE; Albain K; McCulloch JH
J Clin Oncol; 1991 Mar; 9(3):453-7. PubMed ID: 1847967
[TBL] [Abstract][Full Text] [Related]
32. Phase I trial of intravenous carboplatin added to oral etoposide and oral cyclophosphamide for stage IV non-small cell lung cancer.
Grunberg SM; Valentine J; Zackon I; Unger P
Invest New Drugs; 1996; 13(4):333-5. PubMed ID: 8824352
[TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer.
Miller AA; Tolley EA; Niell HB; Griffin JP; Mauer AM
J Clin Oncol; 1993 Jun; 11(6):1179-88. PubMed ID: 8388920
[TBL] [Abstract][Full Text] [Related]
34. Vindesine and etoposide chemotherapy in the management of patients with small cell lung cancer and poor prognosis.
Iredale JP; Hooi LM; Kerr KM; Sudlow MF; Wathen CG
Respiration; 1991; 58(2):77-80. PubMed ID: 1650490
[TBL] [Abstract][Full Text] [Related]
35. Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study.
O'Bryan RM; Crowley JJ; Kim PN; Epstein RB; Neilan B; Coltman CA; Stuckey WJ; Pazdur R
Cancer; 1990 Feb; 65(4):856-60. PubMed ID: 2153435
[TBL] [Abstract][Full Text] [Related]
36. The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer.
Clark PI; Cottier B
Semin Oncol; 1992 Dec; 19(6 Suppl 14):36-9. PubMed ID: 1336898
[TBL] [Abstract][Full Text] [Related]
37. Phase I study and clinical pharmacological evaluation of daily oral etoposide combined with carboplatin in patients with lung cancer.
Ohune T; Fujiwara Y; Sumiyoshi H; Yamaoka N; Yamakido M
Jpn J Cancer Res; 1995 May; 86(5):490-500. PubMed ID: 7790322
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer.
Jassem J; Karnicka-Młodkowska H; Jassem E; Słupek A; Zych J; Wiatr E; Malak S; Moś-Antkowiak R; Szymaczek-Meyer L; Pilarska-Machowicz A
Lung Cancer; 1994 Sep; 11(3-4):283-91. PubMed ID: 7812705
[TBL] [Abstract][Full Text] [Related]
39. A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients.
Correale P; Cerretani D; Remondo C; Martellucci I; Marsili S; La Placa M; Sciandivasci A; Paolelli L; Pascucci A; Rossi M; Di Bisceglie M; Giorgi G; Gotti G; Francini G
Oncol Rep; 2006 Jul; 16(1):133-40. PubMed ID: 16786136
[TBL] [Abstract][Full Text] [Related]
40. Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.
Anderson H; Lind MJ; Thatcher N; Swindell R; Woodcock A; Carroll KB
Cancer Chemother Pharmacol; 1990; 26(1):71-4. PubMed ID: 2157555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
